ALAlena Langaufová

Alena Langaufová

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alena Langaufová has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Viewpoint of the General Population on Health‐Related Recommendations: A Qualitative Content Analysis

    by Tereza Vrbová, Alena Langaufová, Tereza Friessová, Dana Dolanová, Natália Beharková, Petra BúřIlová, Andrea Pokorná

    Rationale: The development of plain language recommendations has become a strategy to bridge the gap between evidence‐based guidelines, primarily addressed to health professionals, and the public's understanding of health issues. Plain language recommendations aim to enhance health literacy and informed decision‐making. Objective: The main aim of our study was to explore views on the different versions of health‐related recommendations. Methods: Participants of our study were asked to share their experiences with reading and understanding health‐related recommendations in the standard language version and plain language version. Data were collected in five focus groups and analysed by qualitative content analysis. Results: Four themes–accessibility, time, attractiveness, and trustworthiness–were established to describe factors influencing people's experience with health‐related recommendations. People need to find and access the recommendation; to read it, they need time, which may be compensated by the topic's attractiveness. Participants perceived trust in the source as an important consideration when deciding whether to follow the recommendation. Conclusion: To obtain specific information, most participants preferred the plain language version of the recommendation. However, some may prefer the standard language version for a more complex picture. Accessibility, time, attractiveness, and trustworthiness should be considered when developing health‐related recommendations for various groups of care recipients and the general lay population. Our findings may contribute to the more effective development of plain language recommendations.

  • Open Access

    Frameworks for adaptation of health guidelines: a systematic survey update

    by Andrea J. Darzi, Kian Torabiardakani, Mahmoud El. Hajj, Jana Khawandi, Nauman Shakeel, Charbel Awad, Mikel Madi, Malgorzata M. Bala, Tina Poklepovic, Rui Wang, et al.

  • Open Access

    Efficiency of Early Warning Scores in Adult Emergency Department and Inpatient Populations: Overview of Reviews

    by Michal Pospíšil, Tereza Friessová, Tamara Skříšovská, Andrea Pokorná, Jan Maláska, Jana Rozmarinová, Alena Langaufová

    Introduction: Early Warning Scores (EWS) are used to support decisions regarding triage and early intervention of patient deterioration in emergency departments (ED) and other clinical environments. We synthesized evidence from systematic reviews on the predictive performance and clinical impact of EWS and their modifications in adult in-hospital populations. Methods: We conducted and reported an overview of reviews following the Joanna Briggs Institute (JBI) methodology, PRIOR statement, and our predefined protocol. A systematic search of MEDLINE (Ovid) and Epistemonikos was performed in May 2025. Two reviewers independently screened studies, extracted data, and critically appraised systematic reviews. We included systematic reviews of adult in-hospital populations evaluating EWS as either prognostic tools for deterioration or mortality, or as interventions implemented within track-and-trigger or rapid response systems. Primary study overlap was quantified using the corrected covered area (CCA). We synthesized evidence narratively and tabularly, emphasizing ED-related data. Results: From 502 records identified, 21 systematic reviews comprising 343 primary studies were included. We identified ED-relevant evidence in 12 reviews. In ED populations, EWS demonstrated moderate-to-good discrimination for mortality and clinical deterioration (National EWS area under the receiver operating characteristic curve (AUROC) values: 0.88 for 24-hour mortality, 0.86 for 48-hour mortality). Across ED and mixed acute-care cohorts, Early Warning Scores also showed fair performance for predicting ICU admission and composite adverse outcomes (AUROC ~0.70–0.75). In sepsis-focused analyses relevant to ED populations, quick Sequential Organ Failure Assessment (qSOFA) demonstrated low sensitivity but high specificity for 28/30-day mortality (sensitivity 0.41, 95% CI, 0.24–0.62; specificity 0.88, 95% CI, 0.81–0.92). The SOFA score showed high sensitivity and moderate specificity for in-hospital mortality (sensitivity 0.89, 95% CI, 0.88–0.90; specificity 0.69, 95% CI, 0.68–0.69). Evidence on the clinical impact of EWS implementation in ED and other emergency settings was limited and heterogeneous. Conclusion: In EDs, Early Warning Scores support early risk stratification and identification of patients at risk of deterioration, particularly for short-term mortality and escalation of care. Their impact on patient-important outcomes remains uncertain. Early Warning Scores should complement clinical judgment, triage systems, and structured escalation protocols. They should not be a standalone tool. Future research should prioritize standardized thresholds, transparent reporting, and rigorous comparative and implementation studies defining the role of EWS in emergency care.

  • Open Access

    Frameworks for adaptation of health guidelines: a systematic survey update

    by Andrea J. Darzi, Kian Torabiardakani, Mahmoud El Hajj, Jana Khawandi, Nauman Shakeel, Charbel Awad, Mikel Madi, Malgorzata M. Bala, Tina Poklepović Peričić, Rui Wang, et al.

    Introduction: Guideline development is both time-consuming and resource-intensive, and duplication of efforts contribute to research waste. Although adopting existing guidelines is an efficient alternative, it often fails to account for contextual factors. Adapting trustworthy, previously developed relevant guidelines offers a promising alternative. Thus, we aimed to identify, describe and evaluate formal frameworks for the adaptation of health-related guidelines.Methods: We updated a previously published systematic survey of guideline adaptation frameworks by searching MEDLINE (Ovid) and Embase (Ovid) from January 1st, 2015, to October 31st, 2025. Eligible studies described an adaptation framework for health guidelines in sufficient detail to allow reproducibility. We excluded reviews, guideline adaptations, and implementation reports. We extracted in duplicate and independently data on framework characteristics and presented results in both narrative and tabular formats.Results: Our search identified 20 guideline adaptation frameworks, up from eight identified in the previous survey. These frameworks included five to 24 steps (median: 13). Each framework followed one of four primary approaches: ADAPTE-based (6/20); GRADE-ADOLOPMENT-based (3/20); hybrid approaches (2/20); and non-systematic approaches (9/20). ADAPTE-based frameworks follow a comprehensive three-phase, 24-step process to assess and modify entire source guidelines. In contrast, GRADE-ADOLOPMENT-based frameworks focus on recommendation-level contextualization using evidence-to-decision frameworks. The remaining frameworks primarily utilize non-systematic methods. The most frequently reported challenges were high resource and expertise requirements, dependence on the quality and availability of source guidelines, contextual and implementation barriers, and limited capacity for new evidence synthesis.Discussion: Guideline adaptation frameworks vary substantially in scope and methods, reflecting a balance between methodological rigor and feasibility. ADAPTE- and GRADE- ADOLOPMENT-based approaches provide structured methods, while more recent frameworks prioritize flexibility. This synthesis will help guideline developers select approaches that best fit their context and resources.

  • Open Access

    Processes for Developing Plain Language Versions of Guidelines Recommendations: A Scoping Review

    by Alena Langaufova, Tereza Friessova, Dana Dolanova, Tereza Vrbova, Petra Burilova, Natalia Beharkova, Andrea Pokorna

    Rationale: Plain language recommendations (PLRs) offer clear and understandable statements based on trustworthy guidelines. Objective: We aimed to synthesise methodological evidence for developing PLRs in the health care context. Methods: We followed the JBI methodology for scoping review development and the PRISMA‐ScR guidelines for scoping review reporting. PLRs in the context of health care guidelines or patient versions of guidelines were included. A systematic search was run in MEDLINE (Ovid), Embase (Ovid), and the repositories of guideline developers until November 2023. Due to the research´s longitudinal nature, the search was updated in May 2025 to verify findings gathered so far. Reviewers extracted data independently and synthesised evidence narratively. Results: In total, 2512 citations and 66 repositories of guideline developers were screened. Nine articles from databases and eight documents representing seven sources of evidence from guideline developers' repositories were included in the final synthesis. Information about PLRs, their development, and methodology were summarised. Various infographics are used when creating PLRs. The target groups of PLRs are, e.g. patients, policymakers, the public, and healthcare providers. The patients could be involved in creating PLRs. The developers can draw from the GIN Public Toolkit, RIGHT‐PVG checklist or DISCERN. Although these methodologies generally cover the development of knowledge translation tools and patients' version of guidelines (PVGs). Numerous tools can be used to translate scientific language and to formulate PLRs. Conclusion: We propose policy support for the conduct and implementation of PLRs for healthcare guidelines drawn from available evidence‐based resources identified by our review. It is desirable to report approaches for communicating recommendations from healthcare guidelines and verify the actionability and understandability of these formats.


  • Open Access

    Equations for Estimating Basal and Resting Metabolic Rates: A Scoping Review Protocol

    by Veronika Pourová, Alena Langaufová, Abanoub Riad

    Objective: This scoping review aims to map the existing equations used for estimating basal and resting metabolic rates and to specify their applicability to various population groups, particularly in cases where they demonstrate higher accuracy based on age, ethnicity, and body mass index (BMI). Methods: The proposed scoping review will be conducted in accordance with the JBI methodology for scoping reviews and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR). A comprehensive search strategy has been developed to identify both published and unpublished studies. The literature search will be conducted in the following databases: MEDLINE (Ovid), EMBASE (Ovid), SportDiscus (EBSCO), and ClinicalTrials.gov. Abstracts will be screened against the inclusion criteria, and the full text of all potential studies will be reviewed by two independent researchers. Data will be extracted using a pre-designed data extraction sheet and presented in tabular form and as a narrative summary. Results: The findings of this review will be disseminated through publication in a peer-reviewed journal and presented as an abstract at specialty conferences. Conclusion: To the best of the authors’ knowledge, this review will be the first to comprehensively map all existing equations for both basal and resting metabolic rates. It is also a pioneering effort in synthesising evidence on the accuracy of these equations. Open Science Framework (OSF) Registration: This project has been registered at OSF since October 3 rd , 2024. https://doi.org/10.17605/OSF.IO/UD4WB

  • Open Access

    Methods and approaches for developing plain language versions of guidelines recommendations: Scoping review protocol

    by Tereza Friessová, Alena Langaufová, Dana Dolanová, Natália Beharková, Tereza Vrbová, Petra Búřilová, Andrea Pokorná

    Aims and Objectives: This is a protocol of a scoping review that will aim to synthesise methodological evidence on formulating plain language versions of recommendations from guidelines both for clinical practice and for public health. Method: We will conduct a search in MEDLINE (Ovid), Embase (Ovid) databases, and webpages of guidelines developers with no language and date limitations. The title/abstract and full‐text screening will be performed by two reviewers independently. The team of reviewers will extract data on methods used for developing plain language versions of recommendations in a standardised manner. The data analysis and synthesis will be presented narratively in tabular form. Results and Conclusion: We will conduct a scoping review based on this protocol.


  • Top Cited Papers
    Open Access

    Midline incisional hernia guidelines: the European Hernia Society

    by David L Sanders, Maciej M Pawlak, Maarten P Simons, Theo Aufenacker, Andrea Balla, Cigdem Berger, Frederik Berrevoet, Andrew C de Beaux, Barbora East, Nadia A Henriksen, et al.

    Since the introduction of anaesthesia by Morton in 1846, and as survivable abdominal surgery became more common, so did the incidence of incisional hernias. Since then, more than 4000 peer-reviewed articles have been published on the topic, many of which have tried to reduce the incidence or introduce techniques to improve outcomes from surgical repair. Despite this, the incidence of incisional hernias and the recurrence rates after repair remain high. A wide range of incisional hernia rates are reported1–5. A meta-analysis including over 14 000 patients reported a weighted incidence of 12.8 per cent 2 years after a midline incision, and that one-third of patients with an incisional hernia undergo surgical repair6. Recurrence rates after repair of incisional hernia range between 23 and 50 per cent, with increasing rates of complications and re-recurrence after each subsequent failed repair7. Arguably, no other benign disease has seen so little improvement in terms of surgical outcome.


  • Open Access

    Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis

    by Salman Hussain, Ambrish Singh, Benny Antony, Jitka Klugarová, M. Hassan Murad, Aarthi S. Jayraj, Alena Langaufová, Miloslav Klugar

    Evidence from preclinical studies suggests a preventive effect of proton pump inhibitors (PPIs) in preeclampsia. Recently, several epidemiological studies have described a conflicting association between the use of PPIs during pregnancy and preeclampsia risk. This study aimed to evaluate the association between PPI use and the risk of preeclampsia. We searched databases, including MEDLINE, Embase, Scopus, Web of Science Core Collection, Emcare, CINAHL, and the relevant grey literature from inception until 13 September 2021. Studies reporting the preeclampsia risk with the use of PPIs were eligible for inclusion. Literature screening, data extraction, and the risk of bias assessment were performed independently by two investigators. Random-effect meta-analysis was performed to generate relative risks (RR) and 95% confidence intervals (CI). The risk of preeclampsia and preterm preeclampsia among women receiving PPIs during pregnancy were the primary outcomes of interest. This meta-analysis comprised three studies involving 4,877,565 pregnant women, of whom 119,017 were PPI users. The included studies were judged to have a low risk of bias. The risk of preeclampsia among pregnant women who received PPIs anytime during pregnancy was significantly increased (RR 1.27 (95% CI: 1.23–1.31)), although the increase was trivial in absolute terms (2 per 1000). The subgroup analysis revealed that the risk was increased in each of the three trimesters. The risk of preterm preeclampsia among pregnant women receiving PPIs anytime during pregnancy was not significantly increased (RR 1.04 (95% CI: 0.70–1.55)). The certainty evaluated by GRADE in these estimates was low. PPI use may be associated with a trivial increase in the risk of preeclampsia in pregnant women. There is no evidence supporting that PPI use decreases the risk of preeclampsia or preterm preeclampsia.